Professor Pete Coffey from University College London (UCL) talks about his stem cell trial results and explains the background to the trials and the chances of the treatment being available as a cure for Macular Degeneration in the near future.
Cathy Yelf, CEO Macular Disease Society, talks about the impact stem cell therapy could have for the majority of people with both the dry and wet forms of AMD.
Coffey @ 6 - 6:50: "We will be initiating a dry [AMD] trial as well ... It is applicable to wet and dry."
